W. Heim
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies 15
- Cancer Treatment and Pharmacology 11
- Peptidase Inhibition and Analysis 2
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 4
- Gastric Cancer Management and Outcomes 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
- Co-authors
- William NovotnyFairooz F. KabbinavarJohn D. HainsworthHerbert I. HurwitzLouis FehrenbacherJordan BerlinEric HolmgrenThomas H. Cartwright
- Cited by
- HepatologyOncologyCancer Research
- Journals
- Journal of Clinical Oncology (13 papers)Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
W. Heim
23 papers receiving 9.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Hepatology 2.0k
- Oncology 6.6k
- Cancer Research 1.7k
- Pulmonary and Respiratory Medicine 3.0k
- Pathology and Forensic Medicine 956
Countries citing papers authored by W. Heim
This map shows the geographic impact of W. Heim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Heim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Heim more than expected).
Fields of papers citing papers by W. Heim
This network shows the impact of papers produced by W. Heim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Heim. The network helps show where W. Heim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W. Heim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 50 | |
| 2 | 2010 | 7 | |
| 3 | 2009 | 2 | |
| 4 | 2007 | 70 | |
| 5 | 2005 | 396 | |
| 6 | Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancerbreakdown → | 2005 | 550 |
| 7 | 2004 | 45 | |
| 8 | Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancerbreakdown → | 2004 | 8433 |
| 9 | 2004 | 2 | |
| 10 | 2004 | 16 | |
| 11 | 2004 | 31 | |
| 12 | 2004 | 23 | |
| 13 | 2004 | 13 | |
| 14 | 2004 | 5 | |
| 15 | 2004 | 21 | |
| 16 | 1994 | 2 | |
| 17 | 1991 | 15 | |
| 18 | 1991 | 23 | |
| 19 | 1991 | 45 | |
| 20 | 1980 | 10 |
About W. Heim
W. Heim is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 10.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (11 papers), Lung Cancer Treatments and Mutations (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Hepatology (2.0k citations), Oncology (6.6k citations) and Cancer Research (1.7k citations). W. Heim has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include William Novotny, Fairooz F. Kabbinavar, John D. Hainsworth, Herbert I. Hurwitz, Louis Fehrenbacher, Jordan Berlin, Eric Holmgren, Thomas H. Cartwright, Napoleone Ferrara and Ari David Baron. Their work appears in journals such as Journal of Clinical Oncology, Cancer, International Journal of Radiation Oncology*Biology*Physics, Journal of Thoracic Oncology and Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.